{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:55:19Z","timestamp":1788580519399,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1124\/dmd.120.090738","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T23:13:08Z","timestamp":1588201988000},"page":"528-536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Regional Proteomic Quantification of Clinically Relevant Non-Cytochrome P450 Enzymes along the Human Small Intestine"],"prefix":"10.1016","volume":"48","author":[{"given":"Haeyoung","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Wolford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1164-5520","authenticated-orcid":false,"given":"Abdul","family":"Basit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert P.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard P.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan H.","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Cyrus","family":"Khojasteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E.","family":"Thummel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagwat","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.120.090738_bib1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1021\/acs.molpharmaceut.7b00772","article-title":"High expression of UGT1A1\/1A6 in monkey small intestine: comparison of protein expression levels of cytochromes P450, UDP-glucuronosyltransferases, and transporters in small intestine of cynomolgus monkey and human","volume":"15","author":"Akazawa","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.120.090738_bib2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1503\/cmaj.120951","article-title":"Grapefruit-medication interactions: forbidden fruit or avoidable consequences?","volume":"185","author":"Bailey","year":"2013","journal-title":"CMAJ"},{"key":"10.1124\/dmd.120.090738_bib3","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/pros.20749","article-title":"Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes","volume":"68","author":"Bao","year":"2008","journal-title":"Prostate"},{"key":"10.1124\/dmd.120.090738_bib4","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1124\/dmd.118.080952","article-title":"Hepatic abundance and activity of androgen- and drug-metabolizing enzyme UGT2B17 are associated with genotype, age, and sex","volume":"46","author":"Bhatt","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.090738_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/cpt.1109","article-title":"Age-genotype-dependent variability in the protein abundance and activity of six major uridine diphosphate-glucuronosyltransferases in human liver [published correction appears in Clin Pharmacol Ther 106:891]","volume":"105","author":"Bhatt","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.120.090738_bib6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/cpt.819","article-title":"Critical issues and optimized practices in quantification of protein abundance level to determine interindividual variability in DMET proteins by LC-MS\/MS proteomics","volume":"103","author":"Bhatt","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.120.090738_bib7","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ejps.2016.09.037","article-title":"IMI - Oral biopharmaceutics tools project - Evaluation of bottom-up PBPK prediction success part 3: identifying gaps in system parameters by analysing in Silico performance across different compound classes","volume":"96","author":"Darwich","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.120.090738_bib8","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s40265-017-0832-z","article-title":"A review of food-drug interactions on oral drug absorption","volume":"77","author":"Deng","year":"2017","journal-title":"Drugs"},{"key":"10.1124\/dmd.120.090738_bib9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/cpt.967","article-title":"Protein abundance of clinically relevant drug-metabolizing enzymes in the human liver and intestine: a comparative analysis in paired tissue specimens","volume":"104","author":"Drozdzik","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.120.090738_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41575-018-0081-y","article-title":"Tales from the crypt: new insights into intestinal stem cells","volume":"16","author":"Gehart","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1124\/dmd.120.090738_bib11","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1124\/dmd.114.059451","article-title":"Identification of diet-derived constituents as potent inhibitors of intestinal glucuronidation","volume":"42","author":"Gufford","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.090738_bib12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1021\/ac201704a","article-title":"Quantification of human uridine-diphosphate glucuronosyl transferase 1A isoforms in liver, intestine, and kidney using nanobore liquid chromatography-tandem mass spectrometry","volume":"84","author":"Harbourt","year":"2012","journal-title":"Anal Chem"},{"key":"10.1124\/dmd.120.090738_bib13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/bdd.2070","article-title":"Optimization of intestinal microsomal preparation in the rat: a systematic approach to assess the influence of various methodologies on metabolic activity and scaling factors","volume":"38","author":"Hatley","year":"2017","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.120.090738_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/bdd.2062","article-title":"Quantifying gut wall metabolism: methodology matters","volume":"38","author":"Hatley","year":"2017","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.120.090738_bib15","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1124\/dmd.116.074377","article-title":"Human enterocytes as an in vitro model for the evaluation of intestinal drug metabolism: characterization of drug-metabolizing enzyme activities of cryopreserved human enterocytes from twenty-four donors","volume":"45","author":"Ho","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.090738_bib16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S1091-255X(97)80130-8","article-title":"Transcriptional activation of the human villin gene during enterocyte differentiation","volume":"1","author":"Hodin","year":"1997","journal-title":"J Gastrointest Surg"},{"key":"10.1124\/dmd.120.090738_bib17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3109\/03602532.2014.973037","article-title":"Transcriptional regulation of human UDP-glucuronosyltransferase genes","volume":"46","author":"Hu","year":"2014","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.120.090738_bib18","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1158\/0008-5472.CAN-15-3372","article-title":"Androgen and estrogen receptors in breast cancer coregulate human UDP-glucuronosyltransferases 2B15 and 2B17","volume":"76","author":"Hu","year":"2016","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.120.090738_bib19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2133\/dmpk.DMPK-13-RG-005","article-title":"Differentiation of human induced pluripotent stem cells into functional enterocyte-like cells using a simple method","volume":"29","author":"Iwao","year":"2014","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.120.090738_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40495-016-0059-9","article-title":"Recent advances in development and application of physiologically-based pharmacokinetic (PBPK) models: a transition from academic curiosity to regulatory acceptance","volume":"2","author":"Jamei","year":"2016","journal-title":"Curr Pharmacol Rep"},{"key":"10.1124\/dmd.120.090738_bib21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1042\/BJ20071136","article-title":"Activators of the farnesoid X receptor negatively regulate androgen glucuronidation in human prostate cancer LNCAP cells","volume":"410","author":"Kaeding","year":"2008","journal-title":"Biochem J"},{"key":"10.1124\/dmd.120.090738_bib22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1124\/dmd.117.078162","article-title":"Clopidogrel carboxylic acid glucuronidation is mediated mainly by UGT2B7, UGT2B4, and UGT2B17: implications for pharmacogenetics and drug-drug interactions","volume":"46","author":"Kahma","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.090738_bib23","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/0140-6736(91)92302-I","article-title":"First-pass metabolism of cyclosporin by the gut","volume":"338","author":"Kolars","year":"1991","journal-title":"Lancet"},{"key":"10.1124\/dmd.120.090738_bib24","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0022-3549(15)00187-2","article-title":"Genetically modified caco-2 cells with improved cytochrome P450 metabolic capacity","volume":"105","author":"K\u00fcblbeck","year":"2016","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.120.090738_bib25","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1124\/dmd.118.082875","article-title":"Cryopreserved human intestinal mucosal epithelium: a novel in vitro experimental system for the evaluation of enteric drug metabolism, cytochrome P450 induction, and enterotoxicity","volume":"46","author":"Li","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.090738_bib26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1517\/17425255.2016.1125882","article-title":"Precision-cut intestinal slices: alternative model for drug transport, metabolism, and toxicology research","volume":"12","author":"Li","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.120.090738_bib27","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ejps.2016.10.036","article-title":"IMI - Oral biopharmaceutics tools project - evaluation of bottom-up PBPK prediction success part 2: an introduction to the simulation exercise and overview of results","volume":"96","author":"Margolskee","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.120.090738_bib28","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ejps.2016.09.027","article-title":"IMI - oral biopharmaceutics tools project - evaluation of bottom-up PBPK prediction success part 1: characterisation of the OrBiTo database of compounds","volume":"96","author":"Margolskee","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.120.090738_bib29","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/pmic.201500433","article-title":"Large-scale multiplex absolute protein quantification of drug-metabolizing enzymes and transporters in human intestine, liver, and kidney microsomes by SWATH-MS: comparison with MRM\/SRM and HR-MRM\/PRM","volume":"16","author":"Nakamura","year":"2016","journal-title":"Proteomics"},{"key":"10.1124\/dmd.120.090738_bib30","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1124\/dmd.105.008672","article-title":"The human intestinal cytochrome P450 \u201cpie\u201d","volume":"34","author":"Paine","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.090738_bib31","first-page":"14","article-title":"First-pass metabolism of midazolam by the human intestine","volume":"60","author":"Paine","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.120.090738_bib32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s40262-015-0351-6","article-title":"Predicting drug extraction in the human gut wall: assessing contributions from drug metabolizing enzymes and transporter proteins using preclinical models","volume":"55","author":"Peters","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.120.090738_bib33","first-page":"152","article-title":"Biomarkers of gut barrier failure in the ICU","volume":"22","author":"Piton","year":"2016","journal-title":"Curr Opin Crit Care"},{"key":"10.1124\/dmd.120.090738_bib34","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.xphs.2016.11.017","article-title":"The promises of quantitative proteomics in precision medicine","volume":"106","author":"Prasad","year":"2017","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.120.090738_bib35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/clpt.2012.65","article-title":"Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology","volume":"92","author":"Rostami-Hodjegan","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.120.090738_bib36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/bdd.2071","article-title":"Revisiting the role of gut wall in the fate of orally administered drugs: why now and to what effect?","volume":"38","author":"Rostami-Hodjegan","year":"2017","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.120.090738_bib37","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1124\/dmd.113.056291","article-title":"Optimized methods for targeted peptide-based quantification of human uridine 5\u2032-diphosphate-glucuronosyltransferases in biological specimens using liquid chromatography-tandem mass spectrometry","volume":"42","author":"Sato","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.090738_bib38","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1124\/dmd.118.082784","article-title":"Physiologically relevant, humanized intestinal systems to study metabolism and transport of small molecule therapeutics","volume":"46","author":"Sawant-Basak","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.090738_bib39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0169-409X(97)00039-2","article-title":"Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction","volume":"27","author":"Shen","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/dmd.120.090738_bib40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1124\/dmd.115.066282","article-title":"Absorption, metabolism, excretion, and the contribution of intestinal metabolism to the oral disposition of [14C]cobimetinib, a MEK inhibitor, in humans","volume":"44","author":"Takahashi","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.090738_bib41","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.clpt.2006.07.007","article-title":"Impact of P-glycoprotein on clopidogrel absorption","volume":"80","author":"Taubert","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.120.090738_bib42","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1172\/JCI34007","article-title":"Gut instincts: CYP3A4 and intestinal drug metabolism","volume":"117","author":"Thummel","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1124\/dmd.120.090738_bib43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/psp4.12170","article-title":"Database of optimized proteomic quantitative methods for human drug disposition-related proteins for applications in physiologically based pharmacokinetic modeling","volume":"6","author":"Vrana","year":"2017","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1124\/dmd.120.090738_bib44","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1124\/jpet.115.226118","article-title":"Regulation of human UGT2B15 and UGT2B17 by miR-376c in prostate cancer cell lines","volume":"354","author":"Wijayakumara","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.120.090738_bib45","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1124\/dmd.104.000794","article-title":"Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi\/AUC) ratios","volume":"32","author":"Williams","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.090738_bib46","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1002\/jps.22568","article-title":"First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics","volume":"100","author":"Wu","year":"2011","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.120.090738_bib47","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1124\/dmd.115.068429","article-title":"Functional comparison of human colonic carcinoma cell lines and primary small intestinal epithelial cells for investigations of intestinal drug permeability and first-pass metabolism","volume":"44","author":"Yamaura","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.090738_bib48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1586\/ecp.13.4","article-title":"Predicting drug-drug interactions: application of physiologically based pharmacokinetic models under a systems biology approach","volume":"6","author":"Yeo","year":"2013","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1124\/dmd.120.090738_bib49","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bcp.2018.08.003","article-title":"Quantitative characterization of UDP-glucuronosyltransferase 2B17 in human liver and intestine and its role in testosterone first-pass metabolism","volume":"156","author":"Zhang","year":"2018","journal-title":"Biochem Pharmacol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624076633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624076633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.120.090738","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:48:12Z","timestamp":1739904492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624076633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0090955624076633"],"URL":"https:\/\/doi.org\/10.1124\/dmd.120.090738","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regional Proteomic Quantification of Clinically Relevant Non-Cytochrome P450 Enzymes along the Human Small Intestine","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.120.090738","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}